Zurcal 40 mg 14 tablets

Tradename:

Zurcal

Composition:

Each tablet contains:

Pantoprazole 40 mg

Auxiliary components:

Sodium carbonate, Mannitol (E421) Crospovidone Povidone K90 Calcium stearate

Properties:

Pantoprazole is a substituted benzimidazole that inhibits the secretion of hydrochloric acid in the stomach by specifically blocking the proton pump of parietal cells. Pantoprazole is converted to its active form, cyclic sulfenamide, in an acidic environment in parietal cells, where it inhibits the enzyme H +, K + -ATPase, i.e. the final stage of the formation of hydrochloric acid in the stomach.

Indications:

gastroesophageal reflux disease, reflux esophagitis;

eradication of Helicobacter pylori (as part of complex therapy);

duodenal ulcer; stomach ulcer;

Zollinger-Ellison syndrome and other pathological hypersecretory diseases.

Method of administration and dosage:

Inside, before meals (usually before breakfast), with the required amount of water. The tablets should be swallowed whole without chewing.

Doses are selected by the doctor depending on the diagnosis.

Adults and adolescents over the age of 12: 1 pantoprazole tablet daily. In some cases, the dose can be increased to 2 pantoprazole tablets per day. It usually takes 4 weeks for treatment. If necessary, the duration of treatment is increased to 8 weeks.

Children under the age of 12:

Pantoprazole is not recommended for use in children under 12 years of age due to limited safety and efficacy data in this age group.

Contraindications:

Hypersensitivity to pantoprazole, benzimidazole derivatives or other components of the drug. Simultaneous reception of atazanavir. Due to insufficient data, the use of pantoprazole for the treatment of children under 12 years of age is not recommended.

Precautionary measures:

In the presence of any alarming symptom (for example, significant weight loss, repeated vomiting, dysphagia, vomiting of blood, anemia, melena) and if a stomach ulcer is present or suspected, malignant neoplasm should be ruled out, since pantoprazole treatment can relieve symptoms and delay diagnosis.

Consideration should be given to the need for additional testing if symptoms persist despite adequate therapy.

Side effects:

In about 5% of patients, side effects of the drug may occur.

The most common side effects: diarrhea and headache – occur in about 1% of patients.

From the nervous system and sensory organs: infrequently – headache, dizziness, sleep disturbance. Rarely, visual acuity, depression (and aggravation). Very rarely – disorientation, paresthesia. The frequency is unknown – hallucinations, confusion (especially in predisposed patients, as well as exacerbation of these symptoms if they were present earlier).

From the gastrointestinal tract: often – stomach polyps (benign). Uncommon – diarrhea, nausea / vomiting, bloating and flatulence, constipation, dry mouth, abdominal pain and discomfort.

Storage method:

in a cool dry place at a temperature not exceeding 25 degrees

Package:

the cardboard box contains 1.2 blisters of 7 or 14 tablets